Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion SR for Smokers Hospitalized with Acute Cardiovascular Disease
NCT00181818Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Bupropion SR with Placebo (2 arms). Primary endpoint: Cotinine-validated 7-day point prevalence tobacco abstinence at 1 year follow-up. Started Oct 1999; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00181818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181818.